13F HOLDINGS REPORT
Boxer Capital, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000895345-23-000296
Total Value
$2.0M
Positions
75
Other Managers
0
Confidential Omitted
No
Holdings (75)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Prometheus Biosciences Inc | 74349U108 | 1,897,500 | $203,640 | 10.00% |
| 2 | Reata Pharmaceuticals Inc | 75615P103 | 1,230,004 | $111,832 | 5.49% |
| 3 | BeiGene Ltd | BEIGF | 500,000 | $107,765 | 5.29% |
| 4 | Sarepta Therapeutics Inc | SRPT | 775,000 | $106,818 | 5.25% |
| 5 | Apellis Pharmaceuticals Inc | APLS | 1,576,000 | $103,953 | 5.11% |
| 6 | Tyra Biosciences Inc | TYRA | 6,448,359 | $103,625 | 5.09% |
| 7 | Revolution Medicines Inc | RVMDW | 4,684,264 | $101,461 | 4.98% |
| 8 | Springworks Therapeutics Inc | 85205L107 | 3,421,541 | $88,070 | 4.33% |
| 9 | Mirati Therapeutics Inc | 60468T105 | 2,000,000 | $74,360 | 3.65% |
| 10 | Cytokinetics Inc | CYTK | 2,100,000 | $73,899 | 3.63% |
| 11 | Amylyx Pharmaceuticals Inc | AMLX | 2,084,000 | $61,145 | 3.00% |
| 12 | Sage Therapeutics Inc | 78667J108 | 1,094,000 | $45,904 | 2.26% |
| 13 | Seagen Inc | SE | 200,000 | $40,494 | 1.99% |
| 14 | Relay Therapeutics Inc | RLAY | 2,169,132 | $35,726 | 1.76% |
| 15 | Merus N V | N5749R100 | 1,900,000 | $34,960 | 1.72% |
| 16 | Viking Therapeutics Inc | VKTX | 2,000,000 | $33,300 | 1.64% |
| 17 | 89Bio Inc | 282559103 | 2,100,000 | $31,983 | 1.57% |
| 18 | Akero Therapeutics Inc | 00973Y108 | 831,495 | $31,813 | 1.56% |
| 19 | Nuvalent Inc | NUVL | 1,210,192 | $31,574 | 1.55% |
| 20 | Ideaya Biosciences Inc | IDYA | 2,202,812 | $30,245 | 1.49% |
| 21 | iTeos Therapeutics Inc | 46565G104 | 2,154,058 | $29,317 | 1.44% |
| 22 | Ventyx Biosciences Inc | 92332V107 | 850,000 | $28,475 | 1.40% |
| 23 | AnaptysBio Inc | ANABV | 1,300,000 | $28,288 | 1.39% |
| 24 | Tango Therapeutics Inc | TNGX | 7,123,642 | $28,138 | 1.38% |
| 25 | Arcus Biosciences Inc | RCUS | 1,432,200 | $26,123 | 1.28% |
| 26 | Amicus Therapeutics Inc | FOLD | 2,325,000 | $25,784 | 1.27% |
| 27 | Rocket Pharmaceuticals Inc | RCKTW | 1,466,051 | $25,113 | 1.23% |
| 28 | Axsome Therapeutics Inc | AXSM | 400,000 | $24,672 | 1.21% |
| 29 | Bellus Health Inc New | 07987C204 | 3,200,000 | $23,040 | 1.13% |
| 30 | Iovance Biotherapeutics Inc | IOVA | 3,705,133 | $22,638 | 1.11% |
| 31 | Exelixis Inc | EXEL | 1,150,000 | $22,322 | 1.10% |
| 32 | Xenon Pharmaceuticals Inc | XENE | 600,000 | $21,474 | 1.05% |
| 33 | Iveric Bio Inc | 46583P102 | 825,000 | $20,072 | 0.99% |
| 34 | Rain Oncology Inc | 75082Q105 | 2,147,212 | $18,767 | 0.92% |
| 35 | Point Biopharma Global Inc | 730541109 | 2,500,000 | $18,175 | 0.89% |
| 36 | Avidity Biosciences Inc | 05370A108 | 1,121,327 | $17,212 | 0.85% |
| 37 | Day One Biopharmaceuticals I | DAWN | 1,189,943 | $15,910 | 0.78% |
| 38 | Enliven Therapeutics Inc | ELVN | 710,644 | $15,563 | 0.76% |
| 39 | PMV Pharmaceuticals Inc | PMVP | 3,163,795 | $15,091 | 0.74% |
| 40 | Prothena Corp PLC | PRTA | 300,000 | $14,541 | 0.71% |
| 41 | Kalvista Pharmaceuticals Inc | KALV | 1,650,000 | $12,969 | 0.64% |
| 42 | Cullinan Oncology Inc | CGEM | 1,074,082 | $10,988 | 0.54% |
| 43 | Nurix Therapeutics Inc | NRIX | 1,224,892 | $10,877 | 0.53% |
| 44 | Ascendis Pharma A/S | ASND | 95,000 | $10,186 | 0.50% |
| 45 | Morphic Hldg Inc | 61775R105 | 200,000 | $7,528 | 0.37% |
| 46 | Oric Pharmaceuticals Inc | ORIC | 1,054,000 | $6,008 | 0.30% |
| 47 | Cogent Biosciences Inc | COGT | 525,000 | $5,665 | 0.28% |
| 48 | Rapt Therapeutics Inc | 75382E109 | 300,000 | $5,505 | 0.27% |
| 49 | Panacea Acquisition Corp II | G6882C106 | 500,000 | $5,110 | 0.25% |
| 50 | Orchestra Biomed Hldgs Inc | OBIO | 250,000 | $4,893 | 0.24% |
| 51 | Centessa Pharmaceuticals PLC | CNTA | 1,251,137 | $4,817 | 0.24% |
| 52 | 2Seventy Bio Inc | 901384107 | 459,836 | $4,690 | 0.23% |
| 53 | Selecta Biosciences Inc | 816212104 | 3,284,072 | $4,565 | 0.22% |
| 54 | Cabaletta Bio Inc | CABA | 540,000 | $4,466 | 0.22% |
| 55 | Gossamer Bio Inc | GOSS | 3,336,928 | $4,205 | 0.21% |
| 56 | Prelude Therapeutics Inc | PRLD | 699,047 | $3,985 | 0.20% |
| 57 | Black Diamond Therapeutics I | BDTX | 2,014,858 | $3,808 | 0.19% |
| 58 | Kinnate Biopharma Inc | 49705R105 | 510,000 | $3,188 | 0.16% |
| 59 | Theseus Pharmaceuticals Inc | 88369M101 | 350,000 | $3,108 | 0.15% |
| 60 | Fate Therapeutics Inc | FATE | 500,000 | $2,850 | 0.14% |
| 61 | Disc Medicine Inc | IRON | 130,000 | $2,755 | 0.14% |
| 62 | Milestone Pharmaceuticals In | MIST | 698,861 | $2,754 | 0.14% |
| 63 | Atreca Inc | 04965G109 | 2,202,333 | $2,511 | 0.12% |
| 64 | DBV Technologies S A | DBVTF | 1,450,000 | $2,451 | 0.12% |
| 65 | Third Harmonic Bio Inc | 88427A107 | 570,417 | $2,350 | 0.12% |
| 66 | NGM Biopharmaceuticals Inc | 62921N105 | 500,000 | $2,040 | 0.10% |
| 67 | EQRx Inc | 26886C107 | 1,000,000 | $1,940 | 0.10% |
| 68 | BioAtla Inc | BCAB | 686,347 | $1,839 | 0.09% |
| 69 | Mereo Biopharma Group PLC | MREO | 2,250,000 | $1,591 | 0.08% |
| 70 | Alaunos Therapeutics Inc | TCRT | 1,500,000 | $945 | 0.05% |
| 71 | MEI Pharma Inc | 55279B202 | 2,913,091 | $667 | 0.03% |
| 72 | Protara Therapeutics Inc | TARA | 209,227 | $655 | 0.03% |
| 73 | Veru Inc | VERU | 347,300 | $403 | 0.02% |
| 74 | Nuvation Bio Inc | NUVB | 266,666 | $32 | 0.00% |
| 75 | Surrozen Inc | SRZNW | 66,666 | $4 | 0.00% |